Publications resulting from human brain tissue obtained from the ABBN.
Alexander-Kaufman K, and Harper C. (2009) Transketolase: observations in alcohol-related brain damage research. Int J Biochem Cell Biol. 41: 717-720.
Boer S, Berk M, and Dean B. (2009) Levels of neuregulin 1 and 3 proteins in Brodmann's area 46 from subjects with schizophrenia and bipolar disorder. Neurosci Lett. 466: 27-29.
Brooks D, and Halliday GM. (2009) Intralaminar nuclei of the thalamus in Lewy body diseases. Brain research bulletin. 78: 97-104.
Cook NL, Vink R, Donkin JJ, and van den Heuvel C. (2009) Validation of reference genes for normalization of real-time quantitative RT-PCR data in traumatic brain injury. J Neurosci Res. 87: 34-41.
Davies RR, Halliday GM, Xuereb JH, Kril JJ, and Hodges JR. (2009) The neural basis of semantic memory: evidence from semantic dementia. Neurobiol Aging. 30: 2043-2052.
Dean B. (2009) Is schizophrenia the price of human central nervous system complexity? Aust N Z J Psychiatry. 43: 13-24.
Dean B, Boer S, Gibbons AS, Money T, and Scarr E. (2009) Recent advances in postmortem pathology and neurochemistry in schizophrenia. Curr Opin Psychiatr. 22: 156-160.
Dean B. (2009) Evolution of the human CNS cholineric system: has this resulted in the emergence of psychiatric disease? Aust N Z J Psychiatry. 43: 1016-1028.
Dean B. (2009) Interpreting the significance of decreased cortical serotonin 2A receptors in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 33: 1583-1584; author reply 1585-1586.
Dedova I, Harding A, Sheedy D, Garrick T, Sundqvist N, Hunt C, Gillies J, and Harper CG. (2009) The importance of brain banks for molecular neuropathological research: the new South wales tissue resource centre experience. International journal of molecular sciences. 10: 366-384.
Dissabandara LO, Dias SR, Dodd PR, and Stadlin A. (2009) Patterns of substance use in male incarcerated drug users in Sri Lanka. Drug Alcohol Rev. 28: 600-607.
Donkin JJ, Nimmo AJ, Cernak I, Blumbergs PC, and Vink R. (2009) Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury. J Cereb Blood Flow Metab. 29: 1388-1398.
Etheridge N, Lewohl JM, Mayfield RD, Harris RA, and Dodd PR. (2009) Synaptic proteome changes in the superior frontal gyrus and occipital cortex of the alcoholic brain. Proteomics Clin Appl. 3: 730-742.
Flatscher-Bader T, and Wilce PA. (2009) The effect of alcohol and nicotine abuse on gene expression in the brain. Nutr Res Rev. 22: 148-162.
Fodero-Tavoletti MT, Mulligan RS, Okamura N, Furumoto S, Rowe CC, Kudo Y, Masters CL, Cappai R, Yanai K, and Villemagne VL. (2009) In vitro characterisation of BF227 binding to αsynuclein/Lewy bodies. European journal of pharmacology. 617: 54-58.
Fodero-Tavoletti MT, Cappai R, McLean C, Pike KE, Adlard PA, Cowie TF, Conner AR, Masters CL, Rowe CC, and Villemagne VL. (2009) Amyloid imaging in Alzeimer's disease and other dementias. Brain Imaging and Behavior. 3: 246-261.
Fodero-Tavoletti MT, Rowe CC, McLean CA, Leone L, Li QX, Masters CL, Cappai R, and Villemagne VL. (2009) Characterization of PiB binding to white matter in Alzheimer disease and other dementias. J Nucl Med. 50: 198-204.
Fornito A, Yucel M, Dean B, Wood SJ, and Pantelis C. (2009) Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology. Schizophr Bull. 35: 973-993.
Garrick T, Sundqvist N, Dobbins T, Azizi L, and Harper C. (2009) Factors that influence decisions by families to donate brain tissue for medical research. Cell and tissue banking. 10: 309-315.
Gibbons AS, Scarr E, McLean C, Sundram S, and Dean B. (2009) Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects. Journal of affective disorders. 116: 184-191.
Gibbons AS, Thomas EA, and Dean B. (2009) Regional and duration of illness differences in the alteration of NCAM-180 mRNA expression within the cortex of subjects with schizophrenia. Schizophr Res. 112: 65-71.
Glaw XM, Garrick TM, Terwee PJ, Patching JR, Blake H, and Harper C. (2009) Brain donation: who and why? Cell and tissue banking. 10: 241-246.
Grunblatt E, Monoranu CM, Apfelbacher M, Keller D, Michel TM, Alafuzoff I, Ferrer I, Al-Saraj S, Keyvani K, Schmitt A, Falkai P, Schittenhelm J, McLean C, Halliday GM, Harper C, Deckert J, Roggendorf W, and Riederer P. (2009) Tryptophan is a marker of human postmortem brain tissue quality. J Neurochem. 110: 1400-1408.
Harper C. (2009) The neuropathology of alcohol-related brain damage. Alcohol Alcohol. 44: 136-140.
Johansson S, Ekstrom TJ, Marinova Z, Okvist A, Sheedy D, Garrick T, Harper C, Kuzmin A, Yakovleva T, and Bakalkin G. (2009) Dysregulation of cell death machinery in the prefrontal cortex of human alcoholics. Int J Neuropsychopharmacol. 12: 109-115.
Joseph V, Wells A, Kuo YH, Halcrow S, Brophy B, Scott G, Manavis J, Swift J, and Blumbergs PC. (2009) The 'rosette-forming glioneuronal tumor' of the fourth ventricle. Neuropathology. 29: 309-314.
Kashem MA, Etages HD, Kopitar-Jerala N, McGregor IS, and Matsumoto I. (2009) Differential protein expression in the corpus callosum (body) of human alcoholic brain. J Neurochem. 110: 486-495.
Kashem MA, Sarker R, Des Etages H, Machaalani R, King N, McGregor IS, and Matsumoto I. (2009) Comparative proteomics in the corpus callosal sub-regions of postmortem human brain. Neurochem Int. 55: 483-490.
Kleinig T, Koszyca B, Blumbergs P, and Thompson P. (2009) Fulminant leucocytoclastic brainstem vasculitis in a patient with otherwise indolent systemic lupus erythematosus. Lupus. 18: 486-490.
Koga M, Ishiguro H, Yazaki S, Horiuchi Y, Arai M, Niizato K, Iritani S, Itokawa M, Inada T, Iwata N, Ozaki N, Ujike H, Kunugi H, Sasaki T, Takahashi M, Watanabe Y, Someya T, Kakita A, Takahashi H, Nawa H, Muchardt C, Yaniv M, and Arinami T. (2009) Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia. Hum Mol Genet. 18: 2483-2494.
Koszyca B, Jones N, Kneebone C, and Blumbergs P. (2009) Localized hypertrophic neuropathy: a case report and review of the literature. Clinical neuropathology. 28: 54-58.
Kragh CL, Lund LB, Febbraro F, Hansen HD, Gai WP, El-Agnaf O, Richter-Landsberg C, and Jensen PH. (2009) αSynuclein aggregation and Ser-129 phosphorylation-dependent cell death in oligodendroglial cells. The Journal of biological chemistry. 284: 10211-10222.
Kretzschmar H. (2009) Brain banking: opportunities, challenges and meaning for the future. Nature reviews. 10: 70-78.
Kuzmin A, Bazov I, Sheedy D, Garrick T, Harper C, and Bakalkin G. (2009) Expression of pronociceptin and its receptor is downregulated in the brain of human alcoholics. Brain research. 1305 Suppl: S80-85.
Lee JH, Lee IH, Choe YJ, Kang S, Kim HY, Gai WP, Hahn JS, and Paik SR. (2009) Real-time analysis of amyloid fibril formation of α-synuclein using a fibrillation-state-specific fluorescent probe of JC-1. Biochem J. 418: 311-323.
Limaye VS, Blumbergs P, and Roberts-Thomson PJ. (2009) Idiopathic inflammatory myopathies. Intern Med J. 39: 179-190.
Luquin N, Yu B, Saunderson RB, Trent RJ, and Pamphlett R. (2009) Genetic variants in the promoter of TARDBP in sporadic amyotrophic lateral sclerosis. Neuromuscul Disord. 19: 696-700.
Mevawalla N, Fung V, Morris J, and Halliday GM. (2009) Unilateral rest tremor in vascular parkinsonism associated with a contralateral lesion of the locus coeruleus. Mov Disord. 24: 1242-1244.
Monoranu CM, Apfelbacher M, Grunblatt E, Puppe B, Alafuzoff I, Ferrer I, Al-Saraj S, Keyvani K, Schmitt A, Falkai P, Schittenhelm J, Halliday G, Kril J, Harper C, McLean C, Riederer P, and Roggendorf W. (2009) pH measurement as quality control on human postmortem brain tissue: A Study of the BrainNet Europe Consortium. Neuropathology and applied neurobiology. 35: 329-337.
Morahan JM, Yu B, Trent RJ, and Pamphlett R. (2009) A genome-wide analysis of brain DNA methylation identifies new candidate genes for sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 10: 418-429.
Narayan S, Head SR, Gilmartin TJ, Dean B, and Thomas EA. (2009) Evidence for disruption of sphingolipid metabolism in schizophrenia. J Neurosci Res. 87: 278-288.
Nesvaderani M, Matsumoto I, and Sivagnanasundaram S. (2009) Anterior hippocampus in schizophrenia pathogenesis: molecular evidence from a proteome study. Aust N Z J Psychiatry. 43: 310-322.
Pamphlett R, Luquin N, McLean C, Jew SK, and Adams L. (2009) TDP-43 neuropathology is similar in sporadic amyotrophic lateral sclerosis with or without TDP-43 mutations. Neuropathology and applied neurobiology. 35: 222-225.
Png GM, Flook R, Ng B-H, and Abbott D. (2009) THz spectroscopy of snap-frozen human brain tissue: an initial study. Electron Lett. 45: 343-345.
Power JH, and Blumbergs PC. (2009) Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies. Acta neuropathologica. 117: 63-73.
Ridge JP, and Dodd PR. (2009) Cortical NMDA receptor expression in human chronic alcoholism: influence of the Taq IA allele of ANKK1. Neurochemical research. 34: 1775-1782.
Ridge JP, Ho AM, and Dodd PR. (2009) Sex differences in NMDA receptor expression in human alcoholics. Alcohol Alcohol. 44: 594-601.
Salah-Uddin H, Scarr E, Pavey G, Harris K, Hagan JJ, Dean B, Challiss RA, and Watson JM. (2009) Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Gα(q/11) coupling in a schizophrenia endophenotype. Neuropsychopharmacology. 34: 2156-2166.
Scarr E, and Dean B. (2009) Role of the cholinergic system in the pathology and treatment of schizophrenia. Expert review of neurotherapeutics. 9: 73-86.
Scarr E, Cowie TF, Kanellakis S, Sundram S, Pantelis C, and Dean B. (2009) Decreased cortical muscarinic receptors define a sub-group of subjects with schizophrenia. Mol Psychiatr. 14: 1017-1023.
Shepherd C, McCann H, and Halliday GM. (2009) Variations in the neuropathology of familial Alzheimer's disease. Acta neuropathologica. 118: 37-52.
Sokolova A, Hill MD, Rahimi F, Warden LA, Halliday GM, and Shepherd CE. (2009) Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease. Brain Pathol. 19: 392-398.
Sutherland GT, Halliday GM, Silburn PA, Mastaglia FL, Rowe DB, Boyle RS, O'Sullivan JD, Ly T, Wilton SD, and Mellick GD. (2009) Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease? Mov Disord. 24: 833-838.
Tang B, Chang WL, Lanigan CM, Dean B, Sutcliffe JG, and Thomas EA. (2009) Normal human aging and early-stage schizophrenia share common molecular profiles. Aging cell. 8: 339-342.
Velakoulis D, Walterfang M, Mocellin R, Pantelis C, Dean B, and McLean C. (2009) Abnormal hippocampal distribution of TDP-43 in patients with-late onset psychosis. Aust N Z J Psychiatry. 43: 739-745.
Velakoulis D, Walterfang M, Mocellin R, Pantelis C, and McLean C. (2009) Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: clinicopathological series and review of cases. Br J Psychiatry. 194: 298-305.
Wang JC, Grucza R, Cruchaga C, Hinrichs AL, Bertelsen S, Budde JP, Fox L, Goldstein E, Reyes O, Saccone N, Saccone S, Xuei X, Bucholz K, Kuperman S, Nurnberger J, Jr., Rice JP, Schuckit M, Tischfield J, Hesselbrock V, Porjesz B, Edenberg HJ, Bierut LJ, and Goate AM. (2009) Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence. Mol Psychiatry. 14: 501-510.
Wang JC, Cruchaga C, Saccone NL, Bertelsen S, Liu P, Budde JP, Duan W, Fox L, Grucza RA, Kern J, Mayo K, Reyes O, Rice J, Saccone SF, Spiegel N, Steinbach JH, Stitzel JA, Anderson MW, You M, Stevens VL, Bierut LJ, and Goate AM. (2009) Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. Hum Mol Genet. 18: 3125-3135.
Watanabe H, Henriksson R, Ohnishi YN, Ohnishi YH, Harper C, Sheedy D, Garrick T, Nyberg F, Nestler EJ, Bakalkin G, and Yakovleva T. (2009) FOSB proteins in the orbitofrontal and dorsolateral prefrontal cortices of human alcoholics. Addict Biol. 14: 294-297.
Wills AM, Cronin S, Slowik A, Kasperaviciute D, Van Es MA, Morahan JM, Valdmanis PN, Meininger V, Melki J, Shaw CE, Rouleau GA, Fisher EM, Shaw PJ, Morrison KE, Pamphlett R, Van den Berg LH, Figlewicz DA, Andersen PM, Al-Chalabi A, Hardiman O, Purcell S, Landers JE, and Brown RH, Jr. (2009) A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology. 73: 16-24.